Rekvina Laboratories Limited Stock

Stocks

VINRKLB

INE092O01028

Delayed Bombay S.E. 13:44:15 06/11/2026 HKT			5-day change	1st Jan Change
61.03 ^INR	+4.99%		+11.21%	+1,256.22%

10-07	Rekvina Laboratories Limited Announces Appointment of Subrata Samanta as Chief Financial Officer, Effective October 07, 2026	CI
10-07	Rekvina Laboratories Limited Announces Appointment of Subrata Samanta as Key Managerial Personnel, Effective October 07, 2026	CI

Valuation: Rekvina Laboratories Limited

Market Cap	646M 6.84M 6.09M 5.57M 5.08M 9.57M 9.82M 66.95M 26.77M 342M 25.66M 25.11M 1.08B	P/E 2025	-19.6x	P/E 2026	-85.6x
Enterprise Value	661M 6.99M 6.23M 5.7M 5.19M 9.78M 10.05M 68.46M 27.38M 350M 26.24M 25.68M 1.1B	EV / Sales 2025	-	EV / Sales 2026	18,372,546x
Free-Float	-	Yield 2025 *	-	Yield 2026	-

* Estimated data More valuation ratios

Chart: Rekvina Laboratories Limited

Dynamic Chart

Latest news: Rekvina Laboratories Limited

10-07	Rekvina Laboratories Limited Announces Appointment of Subrata Samanta as Chief Financial Officer, Effective October 07, 2026	CI
10-07	Rekvina Laboratories Limited Announces Appointment of Subrata Samanta as Key Managerial Personnel, Effective October 07, 2026	CI
09-23	Rekvina Laboratories Limited Approves Change of Address	CI
09-12	Rekvina Laboratories Limited Announces Resignation of Amit Mukesh Shah from Director, Effective September 11, 2026	CI
09-12	Rekvina Laboratories Limited Announces Resignation of Amit Mukesh Shah from Managing Director, Effective September 11, 2026	CI
09-02	Rekvina Laboratories Limited Announces Resignation of Deepak Khandelwal as Company Secretary & Compliance Officer, Effective September 2, 2026	CI
08-14	Rekvina Laboratories Limited Reports Earnings Results for the First Quarter Ended June 30, 2026	CI
08-13	Rekvina Laboratories Limited Announces Appointment of Surbhit Shah as Chairman of the Board	CI
07-14	Surbhit Mukesh Shah, the managing director of Rekvina Laboratories Limited, Amit Mukesh Shah, the director of Rekvina Laboratories Limited and Dhruvalkumar Patel completed the acquisition of an additional 23.22% stake in Rekvina Laboratories Limited for INR 14.41 million.	CI
05-21	Rekvina Laboratories Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2026	CI
03-16	Rekvina Laboratories Limited entered into agreement to acquire Radiant Parenterals Limited from Surbhit Mukesh Shah, Amit Mukesh Shah, Dhruvalkumar Patel, Krima Surbhit Shah and Ami Amit Shah for approximately INR 140 million.	CI
03-16	Surbhit Mukesh Shah and Amit Mukesh Shah, the directors of Rekvina Laboratories Limited and Dhruvalkumar Patel proposed to acquire an additional 47.94% stake in Rekvina Laboratories Limited for INR 28.9 million.	CI
03-11	Rekvina Laboratories Limited announced that it expects to receive INR 4.6 million in funding	CI

More news

Quotes and Performance

1 day	+4.99%
1 week	+11.21%
Current month	+11.21%
1 month	+18.48%
3 months	+119.30%
6 months	+49.69%
Current year	+1,256.22%

More quotes

Price Extremes

1 week	52.14	61.03
1 month	52.14	65.07
Current year	6.75	65.07
1 year	6.75	65.07
3 years	6.75	65.07
5 years	4.5	65.07
10 years	3.6	65.07

More quotes

Managers and Directors: Rekvina Laboratories Limited

Director	Title	Age	Since
Surbhit Shah CHM	Chairman	43	13/08/2026
Ilaben Pathak CHM	Chairman	31	05/10/2024
Prateek Jain BRD	Director/Board Member	-	06/10/2025

More insiders

Financials

	2025	2026
Net sales	-	12.65 0.13 0.12 0.11 0.1 0.19 0.19 1.31 0.52 6.7 0.5 0.49 21.15
Net income	-1.37M -14.51K -12.93K -11.82K -10.77K -20.3K -20.85K -142K -56.81K -726K -54.45K -53.29K -2.29M	-2.55M -26.95K -24.02K -21.97K -20.01K -37.71K -38.73K -264K -106K -1.35M -101K -98.99K -4.26M
Net Debt	2.22M 23.47K 20.91K 19.13K 17.42K 32.84K 33.72K 230K 91.9K 1.17M 88.1K 86.21K 3.71M	14.57M 154K 137K 126K 114K 216K 222K 1.51M 604K 7.72M 579K 566K 24.36M